Building Your Child's Care Team
At a Glance
Managing Juvenile Psoriatic Arthritis (JPsA) requires a team of experts, including a pediatric rheumatologist, ophthalmologist, and dermatologist. Together, they target joint inflammation, monitor for silent eye disease, and treat skin issues to protect your child's long-term health.
Because Juvenile Psoriatic Arthritis (JPsA) can affect the joints, skin, eyes, and emotional well-being, managing it effectively requires more than one specialist. Building a “home base” of experts who communicate with each other is the best way to ensure your child receives comprehensive, aggressive care that targets all aspects of the disease [1][2].
The Core Specialists
Each member of the team plays a specific role in protecting your child’s long-term health and mobility.
- Pediatric Rheumatologist: The “quarterback” of the team. They diagnose the specific JPsA subtype, manage systemic medications like biologics, and monitor for joint damage [3][4].
- Pediatric Ophthalmologist: Essential for detecting “silent” uveitis (eye inflammation). They must use a slit-lamp microscope to see inflammatory cells that are invisible to the naked eye [5][6].
- Pediatric Dermatologist: Necessary if your child has psoriasis skin plaques or significant nail changes. They coordinate with the rheumatologist to choose medications that treat both the skin and the joints simultaneously [7][2].
- Physical/Occupational Therapist: Helps restore joint function, improves strength, and manages enthesitis (pain where tendons meet bone). They can also provide assistive devices or custom exercises to keep your child active [8][9].
- Pediatric Psychologist or Social Worker: Chronic pain and visible skin rashes can significantly impact a child’s mood and body image. Psychological support is a vital component of holistic JPsA care [2][1].
Preparing for Your First Appointment
To get the most out of your initial consultation, coming prepared with a “medical portfolio” will help the specialist make an accurate diagnosis and treatment plan. Bring the following artifacts:
- Symptom Diary: Note when stiffness occurs, how long it lasts, and any history of “sausage-like” swelling in fingers or toes (dactylitis) [10].
- Photo Log: If your child has had rashes, “pitted” nails, or swollen joints that come and go, photos can be invaluable for a doctor who might not see those symptoms on the day of the exam.
- Lab & Imaging Results: Bring copies of previous blood work (specifically ANA, RF, and inflammatory markers like ESR/CRP) and any X-rays or MRIs [11][12].
- Family History: List any blood relatives with psoriasis, psoriatic arthritis, or other autoimmune conditions.
Vetting for Expertise
Not all pediatric specialists have extensive experience with the unique “overlap” of JPsA. When meeting a potential doctor, consider asking:
- “How do you distinguish JPsA from other types of JIA in your practice?”
- “Are you comfortable managing the IL-17 or IL-23 biologics often required for this condition?”
- “How do you monitor for subclinical inflammation (inflammation you can’t see or feel)?” [13][14].
A high-quality care team will welcome your engagement and work with you to reach the target of clinical remission [1].
Common questions in this guide
Which specialists are needed to treat juvenile psoriatic arthritis?
Why does my child with JPsA need to see an ophthalmologist?
What should I bring to my child's first JPsA appointment?
How do I know if a doctor is experienced in treating JPsA?
When does a dermatologist need to be involved in my child's JPsA care?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.How many children with JPsA do you currently manage, and are you familiar with the specific JSpADA scoring tool?
- 2.Which biologics do you prefer when a child has both joint inflammation and skin involvement?
- 3.How do you coordinate care with our ophthalmologist and dermatologist to ensure our treatment targets are aligned?
- 4.Given that JPsA can be aggressive, what is your threshold for escalating from methotrexate to a biologic?
- 5.Do you utilize musculoskeletal ultrasound or MRI to monitor for subclinical inflammation in 'hidden' areas like the spine or entheses?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (14)
- 1
Non-Rheumatic Chronic Comorbidities in Children with Juvenile Idiopathic Arthritis.
Haşlak F, Guliyeva V, Hotaman B, et al.
Turkish archives of pediatrics 2023; (58(2)):212-219 doi:10.5152/TurkArchPediatr.2023.22303.
PMID: 36856360 - 2
The impact of psoriasis on wellbeing and clinical outcomes in juvenile psoriatic arthritis.
Low JM, Hyrich KL, Ciurtin C, et al.
Rheumatology (Oxford, England) 2024; (63(5)):1273-1280 doi:10.1093/rheumatology/kead370.
PMID: 37467079 - 3
The Role of Interleukin-17 in Juvenile Idiopathic Arthritis: From Pathogenesis to Treatment.
Paroli M, Spadea L, Caccavale R, et al.
Medicina (Kaunas, Lithuania) 2022; (58(11)) doi:10.3390/medicina58111552.
PMID: 36363508 - 4
Juvenile Idiopathic Arthritis Treatment Updates.
Onel K, Rumsey DG, Shenoi S
Rheumatic diseases clinics of North America 2021; (47(4)):545-563 doi:10.1016/j.rdc.2021.07.009.
PMID: 34635291 - 5
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Screening, Monitoring, and Treatment of Juvenile Idiopathic Arthritis-Associated Uveitis.
Angeles-Han ST, Ringold S, Beukelman T, et al.
Arthritis & rheumatology (Hoboken, N.J.) 2019; (71(6)):864-877 doi:10.1002/art.40885.
PMID: 31021511 - 6
Bilateral Granulomatous Iridocyclitis Associated with Early-Onset Juvenile Psoriatic Arthritis.
Nieves-Ríos C, Requejo Figueroa GA, Ayala Rodríguez SC, et al.
Case reports in ophthalmological medicine 2022; (2022()):3990406 doi:10.1155/2022/3990406.
PMID: 36249177 - 7
Drug therapy in juvenile spondyloarthritis.
Srinivasalu H, Simpson J, Stoll ML
Current opinion in rheumatology 2024; (36(4)):295-301 doi:10.1097/BOR.0000000000001016.
PMID: 38639758 - 8
A comprehensive overview of juvenile idiopathic arthritis: From pathophysiology to management.
Bansal N, Pasricha C, Kumari P, et al.
Autoimmunity reviews 2023; (22(7)):103337 doi:10.1016/j.autrev.2023.103337.
PMID: 37068698 - 9
Physical and Mechanical Therapies for Lower Limb Problems in Children With Juvenile Idiopathic Arthritis: A Systematic Review With Meta-Analysis.
Fellas A, Hawke F, Maarj M, et al.
Journal of foot and ankle research 2025; (18(4)):e70096 doi:10.1002/jfa2.70096.
PMID: 41189076 - 10
Diagnostic imaging of psoriatic arthritis. Part II: magnetic resonance imaging and ultrasonography.
Sudoł-Szopińska I, Pracoń G
Journal of ultrasonography 2016; (16(65)):163-74 doi:10.15557/JoU.2016.0018.
PMID: 27446601 - 11
Magnetic resonance imaging of the musculoskeletal system in the diagnosis of rheumatic diseases in the pediatric population.
Ożga J, Mężyk E, Kmiecik W, et al.
Reumatologia 2024; (62(3)):196-206 doi:10.5114/reum/190262.
PMID: 39055724 - 12
The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes.
Zisman D, Gladman DD, Stoll ML, et al.
The Journal of rheumatology 2017; (44(3)):342-351 doi:10.3899/jrheum.160717.
PMID: 28148698 - 13
Prevalence of ultrasound and clinical findings suggestive of inflammatory arthritis in children with skin psoriasis.
Coronel L, Gouze H, Gudu T, et al.
Rheumatology (Oxford, England) 2024; (63(5)):1391-1396 doi:10.1093/rheumatology/kead398.
PMID: 37540167 - 14
Exploring nailfold videocapillaroscopy in children with psoriatic arthritis: are there any hidden vascular signatures?
Menentoğlu B, Demirkan FG, Arık SD, et al.
Modern rheumatology 2026; (36(2)):290-298 doi:10.1093/mr/roaf079.
PMID: 40879278
This page provides information on building a care team for juvenile psoriatic arthritis for educational purposes only. Always consult your child's pediatric rheumatologist or healthcare team for specific medical advice and coordination.
Get notified when new evidence is published on Psoriasis-related juvenile idiopathic arthritis.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.